Provided by Tiger Trade Technology Pte. Ltd.

Corcept Therapeutics

110.82
-0.9800-0.88%
Post-market: 110.820.00000.00%19:48 EDT
Volume:1.46M
Turnover:161.10M
Market Cap:11.98B
PE:244.28
High:112.80
Open:111.97
Low:109.40
Close:111.80
52wk High:126.38
52wk Low:28.66
Shares:108.10M
Float Shares:96.44M
Volume Ratio:1.52
T/O Rate:1.51%
Dividend:- -
Dividend Rate:- -
EPS(TTM):0.4537
EPS(LYR):0.8200
ROE:8.23%
ROA:0.47%
PB:16.97
PE(LYR):135.15

Loading ...

S&P 500 to Add Bloom Energy, Illumina and Everpure in September Rebalance

Tiger Newspress
·
Sep 05

Corcept Names Roberto Vieira as President, Oncology in Initial Beneficial Ownership Filing

Reuters
·
Sep 04

Corcept Therapeutics Insider Makes Major Multimillion-Dollar Stock Move

TIPRANKS
·
Aug 29

Corcept Endocrinology President Sean Maduck Disposes of 30,955 Corcept Shares Worth $3.88 Million

Reuters
·
Aug 28

Analysts Offer Insights on Healthcare Companies: Corcept Therapeutics (CORT), Alvotech (ALVO) and Abbott Laboratories (ABT)

TIPRANKS
·
Aug 21

Corcept Therapeutics Director David L. Mahoney Sells 103,606 Shares Worth $12.26 Million

Reuters
·
Aug 21

Corcept Chief Business Officer Gary Charles Robb Sells 10,000 Shares for $1.16 Million

Reuters
·
Aug 19

Corcept Therapeutics Incorporated : Truist Securities Assumes Coverage with Buy Rating; Target Price $164 vs $50

THOMSON REUTERS
·
Aug 18

Truist Adjusts Price Target on Corcept Therapeutics to $164 From $50, Maintains Buy Rating

MT Newswires Live
·
Aug 18

Corcept Therapeutics Earnings Call Signals Accelerating Growth

TIPRANKS
·
Aug 18

Corcept Chief Development Officer William Guyer Disposes of Common Shares Worth $1.85 Million

Reuters
·
Aug 13

Corcept Therapeutics (CORT) Stock Could Be Undervalued Despite Mixed Broader Checks

Simply Wall St.
·
Aug 06

Corcept Chief Accounting & Technology Officer Joseph Douglas Lyon Disposes of 1,540 Common Shares Worth $175,806.40

Reuters
·
Aug 06

We Think That There Are More Issues For Corcept Therapeutics (NASDAQ:CORT) Than Just Sluggish Earnings

Simply Wall St.
·
Aug 05

Why Corcept Therapeutics (CORT) Is Up 19.8% After Boosting 2026 Revenue Guidance And Earnings

Simply Wall St.
·
Aug 04

Corcept CFO Atabak Mokari Sells 79,000 Shares Worth $8.95 Million

Reuters
·
Aug 04

3 High Growth Stocks Investors May Be Missing Right Now

Simply Wall St.
·
Aug 03

Coursera Stock And 2 More Growth Picks Backed By Healthy Balance Sheets

Simply Wall St.
·
Aug 02

OTLK, HBAN, CORT, CAPR, GOSS Trending With Analysts

TIPRANKS
·
Aug 01

LIVE Markets-us Earnings Forecast Jumps Further After Key Reports This Week

Reuters
·
Aug 01